Massivemarkets

PRAX

Praxis Precision Medicines, Inc. Common Stock

Nasdaq · usd

$312.49+7.43 (+2.44%)
As of 5:24:52 AM EST on Nov 19, 2026 · 15-minute delayed

Praxis Precision Medicines, Inc. Common Stock (PRAX) trades at $312.49 (+2.44%) as of 5:24:52 AM EST on Nov 19, 2026, +15.39% over the past month. Market cap is $8.53B, with 8.7 days to cover in short interest.

Stock performance

How Praxis Precision Medicines, Inc. Common Stock (PRAX) stock has performed from one day to one year, with its 52-week range.

+55.34%
+$108.73 over 1Y
$206.46$251.07$295.69$340.30Nov 25Feb 26May 26Aug 26Nov 26$305.19
1D
+0.04%
1W
-11.85%
1M
+15.39%
YTD
+3.55%
1Y
+85.99%
52-wk range
$160.11 – $392.70

Key statistics

Today's trading snapshot for PRAX: day range, open, previous close, volume and market cap.

Day range
$302.82 – $314.72
Open
$304.36
Prev close
$305.06
Volume
425.75K
Market cap
$8.53B
Shares out
27.95M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Praxis Precision Medicines, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
—
P/B
6.77
P/FCF
—
ROE
-28.5%
ROA
-27.4%
Debt/Equity
0.00
Div yield
0.00%

As of Nov 18, 2026

8-K filings

Material corporate events Praxis Precision Medicines, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • Partnership or collaborationNov 12, 2026

    The Company continues to make progress on its recent collaboration with Remagine Labs to develop an iontophoretic transdermal patch for ulixacaltamide. The patch is designed to improve accessibility for ulixacaltamide and is planned to enter the clinic in 2027.

  • On November 9, 2026, Praxis Precision Medicines, Inc. announced its financial results for the quarter ended September 30, 2026.

  • Investor presentationAug 6, 2026

    On August 6, 2026, the Company updated its corporate presentation for use in meetings with investors, analysts and others. The presentation is available in the "Investors + Media" portion of the Company's website at investors.praxismedicines.com and a copy is furnished as Exhibit 99.2 to this Current Report.

  • Partnership or collaborationJul 7, 2026

    the Company entered into a research collaboration and license agreement (the "Agreement") with Remagine Labs, Inc., a developer of electronically controlled transdermal drug delivery systems ("Remagine"), to develop an iontophoretic transdermal patch for the delivery of ulixacaltamide for essential tremor. Under the Agreement, the Company and Remagine will collaborate to apply Remagine's proprietary platform, designed for precise, multi-day active transdermal dosing, to ulixacaltamide

  • On June 29, 2026, the Audit Committee approved the engagement of KPMG LLP ("KPMG") as the Company's new independent registered public accounting firm, effective as of that date.

Dividend history and stock splits

Praxis Precision Medicines, Inc. Common Stock's recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

  • 1-for-15Nov 29, 2023

PRAX short interest

How heavily PRAX is shorted: shares short, days to cover and average daily volume.

Days to cover
8.7
Short interest
4.21M
Avg volume
484.39K

As of · reported to FINRA twice monthly.

PRAX news

The latest news and headlines about Praxis Precision Medicines, Inc. Common Stock (PRAX).

Frequently asked questions

What is the Praxis Precision Medicines, Inc. Common Stock (PRAX) stock price today?

Praxis Precision Medicines, Inc. Common Stock (PRAX) is trading at $312.49 (+2.44% on the day) as of 5:24:52 AM EST on Nov 19, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Praxis Precision Medicines, Inc. Common Stock?

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance.

What is the short interest in PRAX?

As of Oct 30, 2026, PRAX has 4.21M shares short and 8.7 days to cover.

What exchange is PRAX listed on?

Praxis Precision Medicines, Inc. Common Stock (PRAX) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of PRAX with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a PRAX analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.